Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Potential impact of diabetes prevention on mortality and future burden of dementia and disability: a modelling study.

Bandosz P, Ahmadi-Abhari S, Guzman-Castillo M, Pearson-Stuttard J, Collins B, Whittaker H, Shipley MJ, Capewell S, Brunner EJ, O'Flaherty M.

Diabetologia. 2020 Jan;63(1):104-115. doi: 10.1007/s00125-019-05015-4. Epub 2019 Nov 15.

2.

Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis.

Collins B, Kypridemos C, Cookson R, Parvulescu P, McHale P, Guzman-Castillo M, Bandosz P, Bromley H, Capewell S, O'Flaherty M.

Prev Med. 2020 Jan;130:105879. doi: 10.1016/j.ypmed.2019.105879. Epub 2019 Oct 31.

3.

FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.

Collins B, Kypridemos C, Pearson-Stuttard J, Huang Y, Bandosz P, Wilde P, Kersh R, Capewell S, Mozaffarian D, Whitsel LP, Micha R, O'Flaherty M; Food-PRICE Investigators.

Milbank Q. 2019 Sep;97(3):858-880. doi: 10.1111/1468-0009.12402. Epub 2019 Jul 22.

PMID:
31332837
4.

Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.

Huang Y, Kypridemos C, Liu J, Lee Y, Pearson-Stuttard J, Collins B, Bandosz P, Capewell S, Whitsel L, Wilde P, Mozaffarian D, O'Flaherty M, Micha R; Food-PRICE (Policy Review and Intervention Cost-Effectiveness) Project.

Circulation. 2019 Jun 4;139(23):2613-2624. doi: 10.1161/CIRCULATIONAHA.118.036751. Epub 2019 Apr 15.

PMID:
30982338
5.

Comparing Strategies to Prevent Stroke and Ischemic Heart Disease in the Tunisian Population: Markov Modeling Approach Using a Comprehensive Sensitivity Analysis Algorithm.

Saidi O, O'Flaherty M, Zoghlami N, Malouche D, Capewell S, Critchley JA, Bandosz P, Ben Romdhane H, Guzman Castillo M.

Comput Math Methods Med. 2019 Jan 29;2019:2123079. doi: 10.1155/2019/2123079. eCollection 2019.

6.

Impacts of Brexit on fruit and vegetable intake and cardiovascular disease in England: a modelling study.

Seferidi P, Laverty AA, Pearson-Stuttard J, Bandosz P, Collins B, Guzman-Castillo M, Capewell S, O'Flaherty M, Millett C.

BMJ Open. 2019 Jan 28;9(1):e026966. doi: 10.1136/bmjopen-2018-026966.

7.

Age is the main determinant of glycated hemoglobin levels in a general Polish population without diabetes: The NATPOL 2011 Study.

Symonides B, Solnica B, Placha G, Pędzich-Placha E, Rutkowski M, Bandosz P, Gaciong Z, Zdrojewski T.

Adv Clin Exp Med. 2019 May;28(5):659-664. doi: 10.17219/acem/91790.

8.

Depressive symptoms and cardiovascular diseases in the adult Polish population. Results of the NATPOL2011 study.

Piwoński J, Piwońska A, Jędrusik P, Stokwiszewski J, Rutkowski M, Bandosz P, Drygas W, Zdrojewski T.

Kardiol Pol. 2019;77(1):18-23. doi: 10.5603/KP.a2018.0213. Epub 2018 Nov 8.

9.

NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study.

Kalarus Z, Balsam P, Bandosz P, Grodzicki T, Kaźmierczak J, Kiedrowicz R, Mitręga K, Noczyński M, Opolski G, Rewiuk K, Rutkowski M, Sokal A, Średniawa B, Wierucki Ł, Wiśniewski M, Zdrojewski T, Lip GYH.

Kardiol Pol. 2018;76(10):1482-1485. doi: 10.5603/KP.a2018.0193. Epub 2018 Sep 13. No abstract available.

10.

Prevalence and distribution of left ventricular diastolic dysfunction in treated patients with long-lasting hypertension.

Świerblewska E, Wolf J, Kunicka K, Graff B, Polonis K, Hoffmann M, Chrostowska M, Szyndler A, Bandosz P, Graff B, Narkiewicz K.

Blood Press. 2018 Dec;27(6):376-384. doi: 10.1080/08037051.2018.1484661. Epub 2018 Aug 21.

PMID:
30129379
11.

Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark 1991-2007 using the IMPACTSEC model.

Joensen AM, Joergensen T, Lundbye-Christensen S, Johansen MB, Guzman-Castillo M, Bandosz P, Hallas J, Prescott EIB, Capewell S, O'Flaherty M.

PLoS One. 2018 Apr 19;13(4):e0194793. doi: 10.1371/journal.pone.0194793. eCollection 2018.

12.

Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.

Pearson-Stuttard J, Kypridemos C, Collins B, Mozaffarian D, Huang Y, Bandosz P, Capewell S, Whitsel L, Wilde P, O'Flaherty M, Micha R.

PLoS Med. 2018 Apr 10;15(4):e1002551. doi: 10.1371/journal.pmed.1002551. eCollection 2018 Apr.

13.

Explaining the decline in coronary heart disease mortality rates in the Slovak Republic between 1993-2008.

Psota M, Bandosz P, Gonçalvesová E, Avdičová M, Bucek Pšenková M, Studenčan M, Pekarčíková J, Capewell S, O'Flaherty M.

PLoS One. 2018 Jan 10;13(1):e0190090. doi: 10.1371/journal.pone.0190090. eCollection 2018.

14.

Subjective daytime functioning assessment in people with insomnia.

Grabowski K, Nowicka-Sauer K, Zdrojewski T, Rutkowski M, Bandosz P, Nowicki Z.

Psychiatr Pol. 2017 Oct 29;51(5):833-843. doi: 10.12740/PP/68917. Epub 2017 Oct 29. English, Polish.

15.

Forecasted trends in disability and life expectancy in England and Wales up to 2025: a modelling study.

Guzman-Castillo M, Ahmadi-Abhari S, Bandosz P, Capewell S, Steptoe A, Singh-Manoux A, Kivimaki M, Shipley MJ, Brunner EJ, O'Flaherty M.

Lancet Public Health. 2017 May 23;2(7):e307-e313. doi: 10.1016/S2468-2667(17)30091-9. eCollection 2017 Jul.

16.

Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study.

Ahmadi-Abhari S, Guzman-Castillo M, Bandosz P, Shipley MJ, Muniz-Terrera G, Singh-Manoux A, Kivimäki M, Steptoe A, Capewell S, O'Flaherty M, Brunner EJ.

BMJ. 2017 Jul 5;358:j2856. doi: 10.1136/bmj.j2856.

17.

Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: A modelling study.

Pearson-Stuttard J, Bandosz P, Rehm CD, Penalvo J, Whitsel L, Gaziano T, Conrad Z, Wilde P, Micha R, Lloyd-Williams F, Capewell S, Mozaffarian D, O'Flaherty M.

PLoS Med. 2017 Jun 6;14(6):e1002311. doi: 10.1371/journal.pmed.1002311. eCollection 2017 Jun.

18.

Comparing effectiveness of mass media campaigns with price reductions targeting fruit and vegetable intake on US cardiovascular disease mortality and race disparities.

Pearson-Stuttard J, Bandosz P, Rehm CD, Afshin A, Peñalvo JL, Whitsel L, Danaei G, Micha R, Gaziano T, Lloyd-Williams F, Capewell S, Mozaffarian D, O'Flaherty M.

Am J Clin Nutr. 2017 Jul;106(1):199-206. doi: 10.3945/ajcn.116.143925. Epub 2017 May 31.

19.

Estimated reductions in cardiovascular and gastric cancer disease burden through salt policies in England: an IMPACTNCD microsimulation study.

Kypridemos C, Guzman-Castillo M, Hyseni L, Hickey GL, Bandosz P, Buchan I, Capewell S, O'Flaherty M.

BMJ Open. 2017 Jan 24;7(1):e013791. doi: 10.1136/bmjopen-2016-013791.

20.

Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study.

Björck L, Rosengren A, Winkvist A, Capewell S, Adiels M, Bandosz P, Critchley J, Boman K, Guzman-Castillo M, O'Flaherty M, Johansson I.

PLoS One. 2016 Aug 4;11(8):e0160474. doi: 10.1371/journal.pone.0160474. eCollection 2016.

21.

Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States.

Lee JC, Zdrojewski T, Pencina MJ, Wyszomirski A, Lachacz M, Opolski G, Bandosz P, Rutkowski M, Gaciong Z, Wyrzykowski B, Navar AM.

JAMA Cardiol. 2016 Sep 1;1(6):700-7. doi: 10.1001/jamacardio.2016.1585.

22.

Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.

Kypridemos C, Allen K, Hickey GL, Guzman-Castillo M, Bandosz P, Buchan I, Capewell S, O'Flaherty M.

BMJ. 2016 Jun 8;353:i2793. doi: 10.1136/bmj.i2793.

23.

Erratum to "Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach" [Int. J. Cardiol. 207 (2016) 286-291].

O'Flaherty M, Bandosz P, Critchley J, Capewell S, Guzman-Castillo M, Aspelund T, Bennett K, Kabir Z, Björck L, Bruthans J, Hotchkiss JW, Hughes J, Laatikainen T, Palmieri L, Zdrojewski T; Euroheart II Steering Group.

Int J Cardiol. 2016 Jul 1;214:536. doi: 10.1016/j.ijcard.2016.04.121. Epub 2016 Apr 23. No abstract available.

24.

Prevalence of self-reported insomnia in general population of Poland.

Nowicki Z, Grabowski K, Cubała WJ, Nowicka-Sauer K, Zdrojewski T, Rutkowski M, Bandosz P.

Psychiatr Pol. 2016;50(1):165-73. doi: 10.12740/PP/58771. English, Polish.

25.

Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.

Zdrojewski T, Solnica B, Cybulska B, Bandosz P, Rutkowski M, Stokwiszewski J, Gaciong Z, Banach M, Wojtyniak B, Pencina M, Wyrzykowski B.

Kardiol Pol. 2016;74(3):213-23. doi: 10.5603/KP.2016.0029.

26.

Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments.

Critchley J, Capewell S, O'Flaherty M, Abu-Rmeileh N, Rastam S, Saidi O, Sözmen K, Shoaibi A, Husseini A, Fouad F, Ben Mansour N, Aissi W, Ben Romdhane H, Unal B, Bandosz P, Bennett K, Dherani M, Al Ali R, Maziak W, Arık H, Gerçeklioğlu G, Altun DU, Şimşek H, Doganay S, Demiral Y, Aslan Ö, Unwin N, Phillimore P; MedCHAMPS; This publication was prepared with support from and on behalf of the MedCHAMPS consortium members, Achour N, Aissi W, Allani R, Arfa C, Abu-Kteish H, Abu-Rmeileh N, Al Ali R, Altun D, Ahmad B, Arık H, Aslan Ö, Beltaifa L, Ben Mansour N, Bennett K, Ben Romdhane H, Ben Salah N, Collins M, Critchley J, Capewell S, Dherani M, Demiral Y, Doganay S, Elias M, Ergör G, Fadhil I, Fouad F, Gerçeklioğlu G, Ghandour R, Göğen S, Husseini A, Jaber S, Kalaca S, Khatib R, Khatib R, Koudsie S, Kilic B, Lassoued O, Mason H, Maziak W, Mayaleh MA, Mikki N, Moukeh G, Flaherty MO, Phillimore P, Rastam S, Roglic G, Saidi O, Saatli G, Satman I, Shoaibi A, Şimşek H, Soulaiman N, Sözmen K, Tlili F, Unal B, Unwin N, Yardim N, Zaman S.

Int J Cardiol. 2016 Apr 1;208:150-61. doi: 10.1016/j.ijcard.2016.01.031. Epub 2016 Jan 7.

PMID:
26878275
27.

Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach.

O'Flaherty M, Bandosz P, Critchley J, Capewell S, Guzman-Castillo M, Aspelund T, Bennett K, Kabir K, Björck L, Bruthans J, Hotchkiss JW, Hughes J, Laatikainen T, Palmieri L, Zdrojewski T; Euroheart II Steering Group.

Int J Cardiol. 2016 Mar 15;207:286-91. doi: 10.1016/j.ijcard.2016.01.147. Epub 2016 Jan 11. Erratum in: Int J Cardiol. 2016 Jul 1;214:536.

28.

Prevalence, awareness, and control of hypertension in elderly and very elderly in Poland: results of a cross-sectional representative survey.

Zdrojewski T, Wizner B, Więcek A, Ślusarczyk P, Chudek J, Mossakowska M, Bandosz P, Bobak M, Kozakiewicz K, Broda G, Wyrzykowski B, Grodzicki T.

J Hypertens. 2016 Mar;34(3):532-8; discussion 538. doi: 10.1097/HJH.0000000000000823.

PMID:
26771343
29.

Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey.

Zdrojewski Ł, Zdrojewski T, Rutkowski M, Bandosz P, Król E, Wyrzykowski B, Rutkowski B.

Nephrol Dial Transplant. 2016 Mar;31(3):433-9. doi: 10.1093/ndt/gfv369. Epub 2015 Nov 10.

PMID:
26560810
30.

[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population].

Zdrojewski T, Jankowski P, Bandosz P, Bartuś S, Chwojnicki K, Drygas W, Gaciong Z, Hoffman P, Kalarus Z, Kaźmierczak J, Kopeć G, Mamcarz A, Opolski G, Pająk A, Piotrowicz R, Podolec P, Rutkowski M, Rynkiewicz A, Siwińska A, Stępińska J, Windak A, Wojtyniak B.

Kardiol Pol. 2015;73(10):958-61. doi: 10.5603/KP.2015.0182. Review. Polish. No abstract available.

31.

Modelling Future Coronary Heart Disease Mortality to 2030 in the British Isles.

Hughes J, Kabir Z, Bennett K, Hotchkiss JW, Kee F, Leyland AH, Davies C, Bandosz P, Guzman-Castillo M, O'Flaherty M, Capewell S, Critchley J.

PLoS One. 2015 Sep 30;10(9):e0138044. doi: 10.1371/journal.pone.0138044. eCollection 2015.

32.

Correction: The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast.

Gillespie DO, Allen K, Guzman-Castillo M, Bandosz P, Moreira P, McGill R, Anwar E, Lloyd-Williams F, Bromley H, Diggle PJ, Capewell S, O'Flaherty M.

PLoS One. 2015 Jul 24;10(7):e0134064. doi: 10.1371/journal.pone.0134064. eCollection 2015. No abstract available.

33.

The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast.

Gillespie DO, Allen K, Guzman-Castillo M, Bandosz P, Moreira P, McGill R, Anwar E, Lloyd-Williams F, Bromley H, Diggle PJ, Capewell S, O'Flaherty M.

PLoS One. 2015 Jul 1;10(7):e0127927. doi: 10.1371/journal.pone.0127927. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134064.

34.

Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: a modelling study.

Kypridemos C, Bandosz P, Hickey GL, Guzman-Castillo M, Allen K, Buchan I, Capewell S, O'Flaherty M.

PLoS One. 2015 Apr 9;10(4):e0123112. doi: 10.1371/journal.pone.0123112. eCollection 2015.

35.

A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: A modeling study.

Bandosz P, O'Flaherty M, Rutkowski M, Kypridemos C, Guzman-Castillo M, Gillespie DO, Solnica B, Pencina MJ, Wyrzykowski B, Capewell S, Zdrojewski T.

Int J Cardiol. 2015 Apr 15;185:313-9. doi: 10.1016/j.ijcard.2015.03.079. Epub 2015 Mar 10.

PMID:
25828672
36.

Prevalence of diabetes and impaired fasting glucose in Poland--the NATPOL 2011 Study.

Rutkowski M, Bandosz P, Czupryniak L, Gaciong Z, Solnica B, Jasiel-Wojculewicz H, Wyrzykowski B, Pencina MJ, Zdrojewski T.

Diabet Med. 2014 Dec;31(12):1568-71. doi: 10.1111/dme.12542. Epub 2014 Jul 22.

PMID:
24975751
37.

Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing.

Guzman Castillo M, Gillespie DO, Allen K, Bandosz P, Schmid V, Capewell S, O'Flaherty M.

PLoS One. 2014 Jun 11;9(6):e99482. doi: 10.1371/journal.pone.0099482. eCollection 2014.

38.

Epidemiology of physical activity in adult Polish population in the second decade of the 21st century. Results of the NATPOL 2011 study.

Drygas W, Sakłak W, Kwaśniewska M, Bandosz P, Rutkowski M, Bielecki W, Rębowska E, Prusik K, Zdrojewski T.

Int J Occup Med Environ Health. 2013 Dec;26(6):846-55. doi: 10.2478/s13382-013-0160-9. Epub 2014 Jan 25.

39.

Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey.

Zdrojewski T, Rutkowski M, Bandosz P, Gaciong Z, Jędrzejczyk T, Solnica B, Pencina M, Drygas W, Wojtyniak B, Grodzicki T, Piwoński J, Wyrzykowski B.

Kardiol Pol. 2013;71(4):381-92. doi: 10.5603/KP.2013.0066.

PMID:
23788344
40.

Inverse association of serum bilirubin with metabolic syndrome and insulin resistance in Polish population.

Guzek M, Jakubowski Z, Bandosz P, Wyrzykowski B, Smoczyński M, Jabloiska A, Zdrojewski T.

Przegl Epidemiol. 2012;66(3):495-501.

41.

Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study.

Bandosz P, O'Flaherty M, Drygas W, Rutkowski M, Koziarek J, Wyrzykowski B, Bennett K, Zdrojewski T, Capewell S.

BMJ. 2012 Jan 25;344:d8136. doi: 10.1136/bmj.d8136.

42.

Mortality from ischaemic heart disease in Poland in 1991-1996 estimated by the coding system used since 1997.

Jasiński B, Bandosz P, Wojtyniak B, Zdrojewski T, Rutkowski M, Koziarek J, Piotrowski W, Drygas W.

Kardiol Pol. 2010 May;68(5):520-7.

PMID:
20491012
43.

The relationship between resting heart rate and atherosclerosis risk factors.

Piwońska A, Piotrowski W, Broda G, Drygas W, Głuszek J, Zdrojewski T, Kozakiewicz K, Stepaniak U, Bandosz P.

Kardiol Pol. 2008 Oct;66(10):1069-75; discussion 1076-8.

PMID:
19006028
44.

[Tests' application in the assessment of Propedeutics of Internal Diseases. 10 year own experience. Part II].

Jasiel-Wojculewicz H, Zdrojewski T, Rutkowski M, Chwojnicki K, Bandosz P, Kaczmarek J, Sworczak K, Wyrzykowski B, Zalewski S.

Pol Arch Med Wewn. 2006 Mar;115(3):282-7. Polish. No abstract available.

PMID:
18468437
45.

Screening for major cardiovascular risk factors among Members of Polish Parliament as a continuation of health marketing for effective cardiovascular prevention in Poland. Warsaw, May 2006.

Rutkowski M, Zdrojewski T, Bandosz P, Wierucki L, Piwoński J, Piwońska A, Narkiewicz K, Opolski G, Drygas W, Korewicki J, Wyrzykowski B.

Kardiol Pol. 2007 May;65(5):486-92; discussion 493-4.

PMID:
17577845
46.

How to improve cooperation with political leaders and other decision-makers to improve prevention of cardiovascular disease: lessons from Poland.

Zdrojewski T, Babinska Z, Kakol M, Januszko W, Rutkowski M, Bandosz P, Piwonski J, Krupa-Wojciechowska B, Wyrzykowski B.

Eur J Cardiovasc Prev Rehabil. 2006 Jun;13(3):319-24.

PMID:
16926659
47.

[The role of medical university in modern prevention of cardiovascular diseases. Examples from Medical University of Gdańsk].

Zdrojewski T, Wierucki L, Ignaszewska-Wyrzykowska A, Zarzeczna-Baran M, Wojdak-Haasa E, Mogilnaya I, Narkiewicz K, Szczech R, Rutkowski M, Bandosz P, Januszko W, Krupa-Wojciechowska B, Wyrzykowski B.

Przegl Lek. 2005;62 Suppl 3:3-7. Polish.

PMID:
16521909
48.
49.

[Metabolic syndrome in Poland].

Wyrzykowski B, Zdrojewski T, Bandosz P.

Kardiol Pol. 2005 Jun;62 Suppl 2:II30-5. Polish. No abstract available.

PMID:
19813333
50.

Arterial hypertension in Poland in 2002.

Zdrojewski T, Szpakowski P, Bandosz P, Pajak A, Wiecek A, Krupa-Wojciechowska B, Wyrzykowski B.

J Hum Hypertens. 2004 Aug;18(8):557-62. Review.

PMID:
15129232

Supplemental Content

Loading ...
Support Center